The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin.

Berezhnaya, N M

The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin. [electronic resource] - Experimental oncology Mar 2008 - 52-5 p. digital

Publication Type: Journal Article

1812-9269


Animals
Antibiotics, Antineoplastic--administration & dosage
Dose-Response Relationship, Drug
Doxorubicin--administration & dosage
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm--drug effects
Killer Cells, Lymphokine-Activated--drug effects
Lymphocyte Activation--drug effects
Melanoma, Experimental--drug therapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasm Transplantation--immunology
Rhabdomyosarcoma--drug therapy
Tumor Escape--drug effects